Acrivon Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $164k | 33k | 4.92 |
| 2023-09-30 | $254k | 27k | 9.56 |
| 2023-06-30 | $90k | 6.9k | 12.96 |
| 2023-03-31 | $84k | 6.6k | 12.67 |